top headlines
The European Commission has approved Erbitux (cetuximab) in combination with [...]
The US FDA has granted Fast Track Designation to SOTIO [...]
Movers & Shakers
sponsored content
With 89% of AI pilots failing to scale, biopharmas can [...]
Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]
As Rare Disease Day 2026 highlights the challenges faced by [...]
Other news
EpilepsyGTx has partnered with ClearPoint Neuro to support the targeted [...]
Nucleome Therapeutics has strengthened its intellectual property portfolio after the [...]
Novogene Europe has expanded its Cambridge Omics Centre with the [...]
ProMIS Neurosciences has reported the first human evidence that its [...]
Tenpoint Therapeutics has submitted a Marketing Authorization Application (MAA) to [...]
Researchers have developed a new way to precisely control organic [...]
